<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897923/" ref="ordinalpos=3373&amp;ncbi_uid=3186733&amp;link_uid=PMC2897923" image-link="/pmc/articles/PMC2897923/figure/F1/" class="imagepopup">Figure 1. The Wnt/β-Catenin <span class="highlight" style="background-color:">Signaling</span> <span class="highlight" style="background-color:">Pathway</span> and Points of Intervention.  From: Striking the Target in Wnt-y Conditions: Intervening in Wnt <span class="highlight" style="background-color:">Signaling</span> During Cancer Progression. </a></div><br /><div class="p4l_captionBody">Receptor activation upon binding of Wnt 1 or Wnt3A leads to stabilization of β-catenin which localizes to the nucleus where it associates with transcription factors and activates transcription of genes involved in proliferation and tumor progression. In the absence of Wnt, transcription of these genes is prevented by phosphorylation of β-catenin by GSK3β within a destruction complex and its subsequent degradation via the proteasome.</div></div>